Friday, 27 October 2017

AbbVie says Humira sales will balloon to $21 billion in 2020

(Reuters) - AbbVie Inc on Friday forecast its flagship drug Humira to bring $21 billion in sales by 2020, about $3 billion higher than its expectation two years ago.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)